Florio GmbH is a digital health company based in Germany, committed to empowering individuals with rare diseases, particularly hemophilia patients, by providing personalized insights for informed decisions and a fulfilling life beyond their condition. The company's user-centric approach combines medical expertise and state-of-the-art user experience to develop intuitive and convenient digital health products. With a team of approximately 25 experts in medicine, software design and engineering, regulatory affairs, quality management, and data protection, Florio focuses on the development and operation of software medical devices in compliance with quality requirements and European data protection regulations. Established in 2019, the company operates in the Health Care and Medical Devices industries. Although Florio has not disclosed its last investment round or investors, its focus on leveraging digital technology to enhance the everyday lives of individuals with rare diseases demonstrates its potential for meaningful impact and future growth within the healthcare sector.
There is no investment information
No recent news or press coverage available for Florio GmbH.